Angiotensin II type 1 receptor antagonist attenuates lung fibrosis in hyperoxia-exposed newborn rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 340, Issue 1, 2012, Pages 169-175

  Chou, Hsiu Chu ^a   Lang, Yaw Dong ^b   Wang, Leng Fang ^a   Wu, Tzu Ying ^a   Hsieh, Yu Fang ^a   Chen, Chung Ming ^a,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HYPEROXIA; LUNG FIBROSIS; LUNG WEIGHT; NEWBORN; NONHUMAN; OXYGEN SATURATION; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACTINS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BODY WEIGHT; COLLAGEN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HYPEROXIA; LOSARTAN; LUNG; ORGAN SIZE; PREGNANCY; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84055177945     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.186288     Document Type: Article

References (27)

1. Boffa JJ, Tharaux PL, Placier S, Ardaillou R, Dussaule JC, and Chatziantoniou C (1999) Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism. Circulation 100:1901-1908. (Pubitemid 29511144)
2. Burri PH (1974) The postnatal growth of the rat lung. 3. Morphology. Anat Rec 180:77-98.
3. Cairns JA and Walls AF (1997) Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 99:1313-1321. (Pubitemid 27142769)
4. Campbell DJ, Kladis A, and Valentijn AJ (1995) Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. J Cardiovasc Pharmacol 26:233-240.
5. Chen CM, Wang LF, Chou HC, Lang YD, and Lai YP (2007) Up-regulation of connective tissue growth factor in hyperoxia-induced lung fibrosis. Pediatr Res 62:128-133.
6. Chung MP, Monick MM, Hamzeh NY, Butler NS, Powers LS, and Hunninghake GW (2003) Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am J Respir Cell Mol Biol 29:375-380. (Pubitemid 37093996)
7. Couroucli XI, Liang YW, Jiang W, Barrios R, and Moorthy B (2006) Attenuation of oxygen-induced abnormal lung maturation in rats by retinoic acid: possible role of cytochrome P4501A enzymes. J Pharmacol Exp Ther 317:946-954. (Pubitemid 43764096)
8. Dzau VJ, Ellison KE, Brody T, Ingelfinger J, and Pratt RE (1987) A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues. Endocrinology 120:2334-2338. (Pubitemid 17084905)
9. Han RN, Buch S, Tseu I, Young J, Christie NA, Frndova H, Lye SJ, Post M, and Tanswell AK (1996) Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen. Pediatr Res 39:921-929. (Pubitemid 26170968)
10. Kirk JM, Heard BE, Kerr I, Turner-Warwick M, and Laurent GJ (1984) Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis. Coll Relat Res 4:169-182. (Pubitemid 14059781)
11. Lang YD, Hung CL, Wu TY, Wang LF, and Chen CM (2010) The renin-angiotensin system mediates hyperoxia-induced collagen production in human lung fibroblasts. Free Radic Biol Med 49:88-95.
12. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, et al. (2001) Very low birth weight outcomes of the National Institute of Child Health and Human Development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 107:E1.
13. Li X, Rayford H, and Uhal BD (2003) Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am J Pathol 163:2523-2530. (Pubitemid 37466493)
14. Li Z, Carter JD, Dailey LA, and Huang YC (2005) Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type 1 receptor. Environ Health Perspect 113:1009-1014. (Pubitemid 41149630)
15. Manji JS, O'Kelly CJ, Leung WI, and Olson DM (2001) Timing of hyperoxic exposure during alveolarization influences damage mediated by leukotrienes. Am J Physiol Lung Cell Mol Physiol 281:L799-L806.
16. Marshall RP (2003) The pulmonary renin-angiotensin system. Curr Pharm Design 9:715-722.
17. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, McAnulty RJ, and Laurent GJ (2004) Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L156-L164. (Pubitemid 38055871)
18. Marshall RP, McAnulty RJ, and Laurent GJ (2000) Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 161:1999-2004. (Pubitemid 30418143)
19. Morrey C, Brazin J, Seyedi N, Corti F, Silver RB, and Levi R (2010) Interaction between sensory C-fibers and cardiac mast cells in ischemia/reperfusion: activation of a local renin-angiotensin system culminating in severe arrhythmic dysfunction. J Pharmacol Exp Ther 335:76-84.
20. Northway WH Jr, Moss RB, Carlisle KB, Parker BR, Popp RL, Pitlick PT, Eichler I, Lamm RL, and Brown BW Jr (1990) Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 323:1793-1799.
21. Peach MJ (1977) Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57:313-370.
22. Rehan V and Torday J (2003) Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation. Cell Biochem Biophys 38:239-250.
23. Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, Shimokawa H, Sueishi K, and Takeshita A (1997) Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension 30:1621-1627. (Pubitemid 27528114)
24. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, and Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3:349-363. (Pubitemid 34619269)
25. Tryka AF, Witschi H, Gosslee DG, McArthur AH, and Clapp NK (1986) Patterns of cell proliferation during recovery from oxygen injury. Species differences. Am Rev Respir Dis 133:1055-1059. (Pubitemid 16090011)
26. Veerappan A, Reid AC, Estephan R, O'Connor N, Thadani-Mulero M, Salazar-Rodriguez M, Levi R, and Silver RB (2008) Mast cell renin and a local reninangiotensin system in the airway: role in bronchoconstriction. Proc Natl Acad Sci U S A 105:1315-1320. (Pubitemid 351397050)
27. Welty SE (2001) Is there a role for antioxidant therapy in bronchopulmonary dysplasia? J Nutr 131:947S-950S.